Cahaba Research — Birmingham, Alabama

Cahaba Research is a clinical research site located in Birmingham, Alabama, United States 35242.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Cahaba Research has participated in 8 clinical trials.

Therapeutic areas: Type 2 Diabetes, T2D, Influenza -Like Illness.

Sponsors: Eli Lilly and Company, Emergo Therapeutics, Inc., Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cahaba Research?

Cahaba Research has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cahaba Research conducted?

Cahaba Research has 8 clinical trials on record. Their work covers Type 2 Diabetes, T2D, Influenza -Like Illness.

Is Cahaba Research accredited by Crixeo Health?

Yes — Cahaba Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cahaba Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.